Antigen-binding molecules that specifically bind to CD3 and their pharmaceutical uses
TW202639590APending Publication Date: 2026-10-01JIANGSU HENGRUI MEDICINE CO LTD +1
0 Cites 0 Cited by
Patent Information
- Application Number
- TW114145579
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-25
- Filing Date
- 2025-11-21
- Publication Date
- 2026-10-01
Smart Images
Figure TWG2TA001078542_001 
Figure TWG2TA001078542_002 
Figure TWG2TA001078542_003
Abstract
This disclosure relates to antigen-binding molecules that specifically bind to CD3 and their pharmaceutical uses. Specifically, this disclosure relates to the use of antigen-binding molecules that specifically bind to CD3 in the preparation of drugs for treating tumors, autoimmune diseases, and inflammatory diseases.
Need to check novelty before this filing date? Find Prior Art